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Abstract
Background: Colon cancer is one of the leading causes of cancer related deaths. Its impact on African Americans (AAs) is
higher than in the general population both in the incidence and mortality from the disease. Colon cancer aggressiveness in
AAs as well as non-frequent check-ups and follow up in this population have been proposed as ways to explain the
observed discrepancies. These facts made the detection of early carcinogenesis markers in this population a priority.
Materials and Methods: Here, we analyzed 50 colon adenomas from AA patients for both microsatellite instability (MSI) and
the methylation status of SLC5A8 gene. This gene’s product is involved in the transport of butyrate that has anti-
proliferative properties through its effects on histone acetylation and gene expression. A proteomic analysis to check the
expressed histones in adenoma and normal tissues was also performed.
Results: The analyzed samples displayed 82% (n=41) methylation level of SLC5A8 gene in adenomas. The MSI-H (high)
adenoma were about 18% (n=9) while the rest were mostly MSS (microsatellite stable) with few MSI-L (Low). No association
was found between SLC5A8 methylation and the MSI status. Also, there was no association between SLC5A8 methylation
and the sex and age of the patients. However, there were more right sided adenomas with SLC5A8 methylation than the left
sided ones. The proteomic analysis revealed distinct histone expression profiles between normal and adenoma tissues.
Conclusion: SLC5A8 is highly methylated in AA colon adenomas which points to its potential use as a marker for early
detection. The MSI rate is similar to that found in colon cancer tumors in AAs. These findings suggest that both processes
stem from the same epigenetic and genetic events occurring at an early stage in colon carcinogenesis in AAs.
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Introduction
Colon cancer is the third most common form of cancer and the
second leading cause of cancer-related deaths in American adults.
The incidence of this disease in African Americans (AA) is higher
than in the general population [1,2,3]. African Americans are also
more likely to die from colon cancer than others. There are
different participating factors in colon carcinogenesis. Genetic
factors impact gene or genome structures and integrity while
epigenetic parameters have an effect on DNA structure and
expression [4,5,6] while environmental factors such as diet and its
interaction with the gut flora impacts the colon mucosa through
the metabolic products’ effects on colon tissue homeostasis. The
metabolic byproducts are channeled through the colon mucosa by
a set of genes of which the primary function is molecules’
transport. The SLC gene family encodes a group of proteins that
are involved in such transport through cell membranes. Mutations
or lack of expression of these genes have been implicated in many
disorders [7]. SLC5A8, also called SMCT for sodium-coupled
monocarboxylate transporter, is a member of the SLC gene family
and have been extensively studied. This gene is expressed in the
retina, brain, kidney, thyroid and in the gastrointestinal system
[8,9,10,11,12,13].
It has been shown that the SLC5A8 protein sit within the apical
membrane of the intestinal tract where it is involved in the
absorption of short chain fatty acids (e.g. butyrate) into the colon
[10,11]. Butyrate, a byproduct of bacterial fermentation, has been
proven to have anti-proliferative characteristics. As such, SLC5A8
gene product that is involved in its transport through the colon
mucosa have been labeled as a tumor suppressor gene [11,12].
It has also been shown that butyrate impacts cell proliferation
through its effect on histones acetylation status. Histone modifi-
cation is very instrumental in the expression level of genes within
the cell. Consequently, butyrate transport by SLC5A8 gene
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ut     product impacts the expression level of many genes that are likely
involved in the negative control, anti-proliferative, of the cell cycle
within the colon mucosa [12].
This gene’s involvement in cancer has already been highlighted
in many studies. Indeed, Park et al [10] have already shown that
both pancreatic and prostate cancers display an SLC5A8
methylation level of 70% unlike in the adjacent non-tumor tissues
[11].
A similar situation was reported by Bennett et al. in head and
neck squamous cell carcinoma patients [8]. Using a Restriction
Landmark Genomic Scanning technique, they found five
methylation markers among which SLC5A8 gene. The other
genes were SEPT9, FUSSEL18, EBF3 and IRX1 [8]. While
studying posttranslational histones modifications in mixed lineage
leukemia (MLL), Whitman et al., (2008) found that such
modifications are generally associated with a hypermethylation
profile in which SLC5A8 gene plays a central role [13].
A recent study by Thangaraju et al (2008) have shown that
SLC5A8 is silenced in humans, in cell lines and in a mouse model
of colon cancer [12]. Their findings strengthen earlier results by Li
et al [9]. They also proved that the re-expression of SLC5A8 in
colon cancer cell lines in the presence of butyrate leads to
apoptosis through the up-regulation of pro-apoptotic genes and
down-regulation of proliferative genes [12].
Most of the studies on SLC5A8 were done on cancer samples
and none has checked in adenomas. As such, we here propose to
analyze the methylation status of SLC5A8 gene in African
American colon adenomas with the goal of finding early colon
cancer markers in this group of patients to mitigate the high
incidence of the disease in this group. Histones expression profiles
was assessed using a proteomic analysis. Microsatellite instability,
also an early event, was studied and data from both analysis were
compared.
Materials and Methods
Ethics Statement
This study was approved by the Howard University Institutional
Review Board (HUIRB), and the study exempt by HUIRB from
consent form since we used archival samples and the patients
could not be identified.
Study population, and colon adenomas samples
Fifty archived and fresh frozen adenomas from 2003 to 2005
from Howard University were included in this study. All samples
were evaluated and subjected to histological diagnosis by expert
pathologists. Tissues were collected (with approval from above
site’s Institutional Review Boards) and clinical data was obtained
(including race, age, and site of adenomas) with no identifiers. The
adenoma and normal areas were diagnosed by a pathologist (EL,
WG) using the H&E matching slides.
DNA isolation and MSI analysis
The slides were microdissected to pinpoint the adenoma areas
as well as normal areas from at least two slides. A pinpoint DNA
extraction kit was used as recommended by the manufacturers
(Zymo Research). DNA was extracted from fresh frozen adenoma
samples using a Gentra DNA extraction kit (Gentra). The
extracted DNA was used as template in PCR reactions with five
microsatellite markers as previously described [5]. Briefly, markers
for (BAT25, BAT26, NR21, NR22 and NR24) were used to
evaluate MSI status of the analysed adenomas. PCR products
were analyzed in a 3130 ABI GeneScan. The samples displaying
DNA instability at only one of the markers were labeled MSI-L,
those displaying instability with two or more markers were labeled
MSI-H, and those displaying no instability with any of the five
markers tested were labeled MSS.
Sodium bisulfite treatment
DNA (200 to 500 ng) was subjected to a sodium bisulfite
treatment to convert unmethylated cytosine to thymidine. A
ZymoResearch DNA Easy Methylation kit was used according to
the manufacturers’ instructions. In brief, The DNA is incubated at
50u C for 16 hours in the presence of the conversion reagent, and
then transferred to a column where it is being desulphonated for
15 min before its elution in 10 ml of elution buffer.
Methylation-specific MS-PCR
The converted DNA was used as template in PCR reactions
using two sets of primers: primers that selectively amplify
methylated DNA: SLC5A8-M-F: 59-TCGAACGTATTTC-
GAGGC and SLC5A8-M-R: 59-ACAACGAATCGATTTTCCG
[9]. The second set of primers to amplify unmethylated DNA had
the following sequences: SLC5A8-U-F: 59-TTGAATGTATTTT-
GAGGTG and SLC5A8-U-R: 59-TCAATTTTCCAAAATCCC
(Invitrogen, Carlsbad, CA) [9]. PCR reactions were performed
using the primer pairs described above in the following reaction
mix: 10X PCR buffer [16.6 mM ammonium sulfate, 67 mM Tris
(pH 8.8), 6.7 mM MgCl2, and 10 mM 2-mercaptoethanol],
dNTPs (each at 1.25 mM), primers (50 pmol each per reaction),
and bisulfite-modified DNA (50 ng) in a final volume of 50 ml.
Reactions were hot-started at 95uC for 5 min, after which 1.25
units of Taq polymerase (Life Technologies, Inc.) were added.
PCR parameters for both sets of primers were: 95uC for 15 min
followed by 40 cycles of 95uC for 30 s, 56uC for 45 s, 72uC for
45 s, and a final step of 72uC for 10 min then 4uC to cool.
Controls for methylated and unmethylated DNA were DNA from
the SW48 colon cancer cell line (ATCC, VA) and normal
lymphocytes, respectively. Each PCR reaction product (10 ml) was
directly loaded into a 2% agarose gel, which was later stained with
ethidium bromide to allow DNA visualization under UV
illumination. The presence of a band with primers specific for
unmethylated DNA and its absence with those specific for
methylated DNA qualified the analyzed adenoma as unmethy-
lated. However, when a band for methylated DNA was present for
the analyzed adenoma, we defined the sample as methylated
(Figure 1) (or semi-methylated if both unmethylated and
methylated bands were displayed on gel).
Figure 1. MSP analysis of the promoter region of SLC5A8 in
five patients with adenoma. The presence of visible PCR product in
lanes ‘‘U’’ indicates the presence of unmethylated genes of SLC5A8, the
presence of product in lanes ‘‘M’’ indicates the presence of methylated
genes. Water controls for PCR reaction are also shown as NT: no
template. MSP of SLC5A8 in NB: Normal Blood lymphocyte DNA used as
control for unmethylated at SLC5A8, SW48: colon cancer cell line used
as a positive control. Patients # 3–5 are methylated, and patients # 1–
2 are semimethylated.
doi:10.1371/journal.pone.0020216.g001
Distinct Gene Methylation in Colon Cancer
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20216Immunohistochemistry
Tissue sections on positively charged slides were prepared from
formalin-fixed, paraffin-embedded specimens Four-micron thick
sections were cut by microtome (Leica Microsystems, Inc.,
Bannockburn, IL) and transferred to adhesive-coated slides. The
slides were de-paraffinized by heating at 55uC for 30 min and by
three 5-min washes with xylene. Tissues were rehydrated by a
series of 5-min washes in 100%, 95%, and 80% ethanol and
distilled water. Antigen retrieval was accomplished by heating the
tissues at 95uC for 12 min in 10 mmol/L sodium citrate (pH 6.0).
Tissue were immunostained using the avidin-biotin-peroxidase
method. After blocking with universal blocking serum (DAKO
Diagnostic, Mississauga, Ontario, Canada) for 30 min, tissues
were incubated with a polyclonal anti-SLC5A8 antibody (provided
by as a gift by V. Ganapathy). at 4uC overnight. Then sections
were incubated with biotin-labeled secondary antibody and
streptavidin-peroxidase for 30 minutes each (DAKO Diagnostic).
Tissues were developed with a 3, 39-diaminobenzidine substrate
(Vector Laboratories, Burlington, Ontario, Canada) and counter-
stained with hematoxylin. Negative controls were created by
omitting the anti-SLC5A8 antibody during primary antibody
incubation (Figure 2).
Two pathologists (EL, WG) blinded to tissue origins scored
stained tissue sections for intensity of SLC5A8 immunostain and
percent of cells stained. Intensity of stain was ranked subjectively
on a scale of 0 to 3, where ‘‘0’’ represents the absence of staining
and ‘‘3’’ is maximal staining. The percent of cells stained was
estimated on a scale of 0 to 3, with 0 for 0%, 1 for 1–33%, 2 for
34–66%, and 3 for greater than 66% of cells stained. SLC5A8
expression score for each core section was calculated as the
product of immunostain intensity and the percent of cells stained.
Proteomic analysis
Adenoma and normal areas were extracted as described before
[14] from sectioned FFPE samples. Extracted peptides from
adenoma and normal regions were separately subjected to Liquid
Chromatography-Mass Spectrometry-Mass Spectrometry/Mass
Spectrometry (LC-MS-MS/MS). Data were searched against
human database and analyzed by Visualize software. After
stringent filtration, 161 proteins were found to be expressed by
the adenoma and 105 by the normal region (Figure 3). Of these,
103 proteins were found to be exclusively expressed by the
adenoma (Table 1). Furthermore, we analyzed the protein
expression levels between the normal and the adenoma. Of the
58 proteins that were expressed in both normal and adenoma, 51
proteins showed either ,1.5 or .1.5 fold change in adenoma
when compared to the control sample (Table 2).
Statistical analysis
To establish correlations between SLC5A8 methylation and
other parameters, different statistical analysis were performed. For
categorical variables, such as MSI status, patient gender and
adenoma location, we used a chi-square test. For SLC5A8
Figure 2. SLC5A8 expression in human colon normal and adenoma. Characteristic cytoplasmic staining of normal colon, and adenoma, was
determined by immunohistochemistry, using antibodies against SLC5A8 (A), and negative control without primary antibody (B). Original
magnifications, 64 magnification, except for enlargements (insets), which are 640.
doi:10.1371/journal.pone.0020216.g002
Figure 3. Adenoma and normal areas were extracted from
microdissected of FFPE samples. Extracted peptides from adenoma
and normal regions were separately subjected to LC-MS-MS/MS. Data
were searched against human database and analyzed by Visualize
software. After stringent filtration, 161 proteins were found to be
expressed by the adenoma and 105 by the normal region . Of these, 103
proteins were found to be exclusively expressed in the adenoma.
doi:10.1371/journal.pone.0020216.g003
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SLC5A8 methylation vs. type of adenomas, the Fisher exact test
was used.
Results
Characteristics of patient samples
Of the 50 patient samples included in this study, 28 (56%) were
male and 22 (44%) were females (Table 1). The mean age in this
group of patients was 62.5 years. The mean age in both male and
females was similar, 62.14 for female patients and 62.78 for male
patients. Twenty three (46%) of the samples were located on the
right side of the colon while 17 (34%) were specifically left sided
(Table 1). For ten patients (20%), the samples were from both sides
of the colon. Twenty four (48%) of the samples were tubular
adenomas, 14 (28%) were tubulovillous adenomas, 2 (4%) were
villous adenomas, 5 (10%) were adenocarcinomas and 5 (10%)
were polyps. For the adenocarcinoma samples, DNA was
extracted from the adenomas sites on the slides.
Microsatellite instability
DNA from the 50 samples was analyzed for microsatellite
instability, a phenotype that is the result of mutation or epigenetic
silencing of DNA mismatch repair genes such as MLH1 genes.
The samples were classified into three categories depending on
how many tested markers showed instability with MSI-H: 2 or
more markers, MSI-L: one marker and MSS: stable for all markers
(Table 1). Within the 50 samples, 9 (18%) displayed instability at 2
or more markers and as such are MSI-H, 10 (20%) were MSI-L
and 31 (62%) were MSS. Five MSI-H (55.5%) were right sided
while 2 (22.2%) were left sided, another 2 (22.2%) were located on
both sides of the colon. For the non-MSI-H samples, 19 (46.3%)
were right sided while 15 (36.6%) were left sided, another 7 (17%)
were on both sides of the colon.
SLC5A8 methylation
The methylation specific PCR analysis of the 50 samples using
SLC5A8 specific primers revealed that 82% (41) samples were
methylated at this gene level (Figure 1 & Table 1).
SLC5A8 methylation and patient gender
A statistical analysis using the Pearson chi-square test has
revealed that SLC5A8 methylation distributes equally among the
two genders. Nineteen female patients and 22 male patients
displayed methylation. The p-value (0.477) showed that there were
no statistically significant difference between the two genders
(Table 1).
SLC5A8 methylation and patient age
The mean age for patients with unmethylated SLC5A8 was
58.22 (Std. Dev. 9.03) while the patients with methylated SLC5A8
gene had an average age of 63.43 (Std. Dev. 13.78). Using a t test,
the difference between the two groups was not found to be
statistically significant with a p- value of 0.2851 (Table 1).
SLC5A8 methylation and tumor location
Forty samples that were clearly defined as right or left sided were
included inthisanalysisusing the Pearson chi2 method.Twentyone
(91.30%) right sided samples were methylated for SLC5A8 while
only 2 (8.7% were unmethylated. Twelve left sided (70.59%)
samples were methylated while 5 (29.41%) were unmethylated. A p-
value of 0.088 reflects a tendency for SLC5A8 to associate more
with the right colon samples than the left ones (Table 1).
SLC5A8 methylation and the MSI status
For this analysis, MSI-L and MSS samples were grouped
together as non MSI-H adenomas. Two (22%) MSI-H samples
were unmethylated while 7 (78%) were methylated. Within the
non MSI-H group , 7 (17%) samples were unmethylated while
34 (82.93%) were methylated. A p-value of 0.716 reflected that
there was no difference of statistical significance between the
two groups and as such the data don’t support any associa-
tion between the MSI status and SLC5A8 methylation
(Table 1).
Table 1. SLC5A8 methylation and clinicopathological properties colon adenoma.
SLC5A8 unmethylated SLC5A8 methylated P value
Mean (SD) age 58 (3.0) 63 (2.2) 0.29
Gender 0.48
Female 3 (14%) 19 (86%)
Male 6 (21%) 22 (79%)
Colon Location of samples 0.09
Right colon 2 (%) 21 (91%)
Left Colon 5 (29%) 12 (71%)
MSI status 0.72
MSI-L 7 (17%) 34 (83%)
MSI-H 2 (22%) 7 (78%)
doi:10.1371/journal.pone.0020216.t001
Table 2. SLC5A8 methylation and its relation with the colon
adenoma subtype and adenocarcinomas.
SLC5A8 unmethylated
(%)
SLC5A8 methylated
(%) P value
TA 4 (17) 20 (83) 0.73
TVA 2 (14) 12 (86)
VA 1 (50) 1 (50)
Adenoca. 1 (20) 4 (80)
Polyp 1 (20) 4 (80)
doi:10.1371/journal.pone.0020216.t002
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SLC5A8 methylation profile was similar in all 5 categories of
samples used (TA, TVA, VA, AdeCA, and polyps) except for
villous adenomas for which we had only two samples. The overall
methylation rate was around 80% which is similar to the
methylation rate obtained in all 50 samples combined (Table 2).
Immunohistochemistry
We performed immunohistochemistry on several adenomas
using an antibody that is specific to SLC5A8 protein (provided by
as a gift by V. Ganapathy). In the analysed specimens, all
adenomas showed no staining with the antibody while normal
tissue did (Figure 2). Adenomas cytoplasmic staining were scored 3
(greater than 66% of cells stained). These results further confirm
the methylation data and their effect on the gene’s expression.
Proteomics
A proteomic analysis from colon adenomas and matched
normal has been performed. The extracted peptides were run
through an LC-MS-MS/MS. Data were searched against human
database and analyzed by Visualize software. After stringent
filtration, 161 proteins were found to be expressed by the adenoma
and 105 by the normal region (Figure 3). Of these, 103 proteins
were found to be exclusively expressed by the adenoma.
Furthermore, we analyzed the protein expression levels between
the normal and the adenoma. Of the 58 proteins that were
expressed in both normal and adenoma, 51 proteins showed either
,1.5 or .1.5 fold change in tumor when compared to the control
sample. Of note SLC5A8 transported compound, butyrate affects
chromatin structure through its effect on histones. The proteomic
data revealed that there are some histones that are specifically
expressed in adenomas (H2A type 2a and Histone 2B type 1) while
others were at least two folds more expressed in adenoma
compared to normal (H2A type3, type1, type1-C, type 1-E,
histone H3.3 and H3.1) that were all 2.64 folds more in adenomas.
Histones H2A type 1-F and H2A/z were 3.19 folds more in
adenoma while Histones H2A type4 and histone 4 were 4.09
and4.27 folds more in adenoma than normal respectively.
Discussion
Earlier studies have checked the methylation status of SLC5A8
gene in many cancerous tissue and cell lines: prostate, head and
neck, pancreas, colon and blood. All of these studies have pointed
to a high methylation level of this gene among others
[8,9,10,13,15]. SLC genes are known to be involved in the
transport of many solutes that differ from one gene to another and
for the same gene from one organ to the other [7] SLC5A8 gene is
involved in the transport of butyrate, propionate, and pyruvate, all
of which are inhibitors of histone deacetylases [16]. SLC5A8 acts
on colon tissue homeostasis mainly through its transport of
butyrate, a byproduct of gut flora metabolism. Indeed, in colon
cancer cell lines that were demethylated by 5-aza-cytidine, an up-
regulation of pro-apoptotic and down-regulation of anti-apoptotic
genes was noticed only if butyrate was supplemented in the
medium [12].
In this study, we established the methylation status of SLC5A8
in colon adenomas in African Americans, a population at high risk
of developing colon cancer. Our finding that 82% of samples were
methylated strengthen earlier findings in cancerous samples and
point to the early occurrence of this methylation in the
carcinogenic process. Our recent CpG islands microarray analysis
of different types of adenomas further confirmed our findings [17].
In these microarray studies, SLC5A8 gene came out always
methylated. The MSI analysis have displayed an 18% MSI-H rate
that is similar to the one obtained with a study of 222 AA colon
carcinomas that showed 19.8% MSI-H [6]. As such both
microsatellite instability and SLC5A8 methylation occur very
early in colon tumorigenesis. However, since not all tumors are
initiated as a result of DNA MMR defects in expression or
sequence, microsatellite instability phenotype would only define a
small subset of tumors (,20%). The co-occurrence of SLC5A8
methylation and the MSI phenotype in our samples might also
point to the fact that both result from the same methylation event
since the MSI phenotype is generally caused by an epigenetic
silencing of DNA mismatch repair genes. Within the MSI-H
group, 22% were not methylated for SLC5A8, also 83% SLC5A8
methylated samples were non-MSI-H. These data reflects that
there is some level of specificity during the DNA methylation
process. Indeed, our statistical analysis has clearly shown that there
was no association between SLC5A8 methylation and the MSI
phenotype. DNA methylation is known to be part of the aging
process. Our data with SLCA8 methylation seems to be non-age
specific. Many of the patients in this study were not very old and
the difference in age between the groups SLC5A8 methylated vs.
unmethylated was not statistically significant. Consequently the
high level methylation observed in this study is likely linked to the
tumorigenic process. It is noteworthy that the mean age of our
group of patients (62.5 years) is in agreement with the data
obtained with our large scale study of 222 colon carcinoma in AAs
[6]. There was 44% of patients in this study who were over 60
years while Kumar et al (2008) reported 64.9% of AA colon cancer
patients over that age. Sex-wise, SLC5A8 methylation was evenly
distributed between male and female patients. It has already been
reported [18] that certain loci are differentially methylated
between the two genders. Such is not the case for SLC5A8, at
least within the colon tissue where its function does not seem to
have any gender specific particularity. There was a noticeable
trend to have SLC5A8 methylation linked to samples that are right
sided. Ninety one percent of right sided samples vs. 70.59% left
sided were methylated. Proximal colon is known to be the site of
more methylation events than the distal one [15,19]. SLC5A8
methylation distributed equally among the 5 different categories of
samples used in this study. Tubulovillous, tubular, adenocarcino-
ma and polyps all showed a similar level of SLC5A8 methylation
(,80%) that was comparable to the value with the entire 50
samples analyzed here. Villous adenomas (n=2) showed 50%
methylation, a rate mainly attributed to the low number of
samples from this category. Consequently, the methylation level
seems not to be associated with any specific kind of adenomas in
our group of African American patients. Dong et al., have pointed
to a major role of SLC5A8 methylation in the early stages leading
to serrated lesions [20] while Goldstein et al., has reported that
SLC5A8 methylation along with BRAF mutation are major actors
in the initiation of sessile serrated adenomas[21]. The recently
named serrated adenoma correspond to adenomas with combined
architectural features of hyperplastic polyps and classical adeno-
ma. Most of the samples in this study are archived samples that
have been classified prior to the advent of sessile adenomas
nomenclature. It would not be surprising to find that some might
fall in this group. However and since BRAF mutation seems to
associate with SLC5A8 methylation in this group of adenomas, it
would be unlikely. Indeed, BRAF mutation in African American
colon cancer samples based on our previous study of 222 samples
was found only in 7 cases out of 222 [6].
It is noteworthy to remember that butyrate, that is being
transported by SLC5A8 gene product, has a direct impact on
histones acetylation status. Ueno et al, have shown that in gastric
Distinct Gene Methylation in Colon Cancer
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e20216cancer samples, histone H3 acetylation correlated directly with
SLC5A8 expression and inversely with DNA methylation [22].
Our laboratory has already established that there was a direct
correlation, that was statistically significant , between HDAC2
expression and colon cancer development in AAs [23]. Also,
H3K12 and H4K18 acetylation status was decreased from normal
to cancer AA samples although not in a statistically significant
manner. These findings put together piece some elements of the
puzzle of AA colon carcinogenesis where SLC5A8 and HDAC2
expression play major roles through their combined effects on
gene expression.
The proteomic data also revealed a higher expression of many
histones 2A of different types in adenomas vs. normal tissues.
Histones 2A are known to affect chromatin structure and thus
gene expression [24]. Li and Jun reported that butyrate induces
profound changes in the expression of at least 450 genes in bovine
kidney epithelial cells [25]. Such a tremendous effect would only
be possible through chromatin remodeling where histones are
involved.
The high level of SLC5A8 methylation in our study also fits the
general picture about genes’ methylation in AA colon cancer. A
recent study from our laboratory revealed that AAs, when
compared to Iranian patients, have higher levels of methylation
at 13 candidate cancer genes [26,27]. This methylation, like
SLC5A8 methylation, was age and sex independent highlighting
an important role of hypermethylation in AA colon carcinogenesis.
Our exclusive choice to work with adenomas, and our inclusion of
5 polyps in this study strengthen that assumption and qualify
SLC5A8 gene as a potential marker for early detection in this high
risk group of patients.
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